Axogen to acquire BioCircuit Technologies for $200M in cash
Axogen, Inc. (NASDAQ: AXGN) has entered into a definitive agreement to acquire BioCircuit Technologies, Inc., a privately held medical device ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
